HIF1A and lung carcinoma: This study demonstrated that 25 μg/ml Endostar inhibited expression of HIF-1 with the upregulation of MHC class I α-heavy chain and β2 m light chain in A549 and NCI-H1299 lung cancer cells, suggesting the potential for Endostar to facilitate cancer immunotherapy.